ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,313.67
1.22%
Dow Jones
38,884.26
0.08%
Gold vs US Dollar
2,315.45
0.02%
Brent Oil
82.825
-0.05%
Bitcoin
62,231.43
-0.17%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE
  6. Alnylam Pharmaceuticals Inc (0HD2)

  7. Alnylam Pharmaceuticals Inc (0HD2) Forum

0HD2 Alnylam Pharmaceuticals Inc

100.80
0.00 (0.00%)
07 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Alnylam Pharmaceuticals Inc LSE:0HD2 London Ordinary Share ALNYLAM PHARMACEUTICALS ORD SHS
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 100.80 - 299 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 1.83B -440.24M -3.5081 -43.97 19.36B
Alnylam Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker 0HD2. The last closing price for Alnylam Pharmaceuticals was US$100.80. Over the last year, Alnylam Pharmaceuticals shares have traded in a share price range of US$ 100.80 to US$ 100.80.

Alnylam Pharmaceuticals currently has 125,493,000 shares in issue. The market capitalisation of Alnylam Pharmaceuticals is US$19.36 billion. Alnylam Pharmaceuticals has a price to earnings ratio (PE ratio) of -43.97.

Alnylam Pharmaceuticals Share Discussion Threads

No Forum Threads FoundAdd a New Thread

Your Recent History

LSE
0HD2
Alnylam Pharmaceuticals
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved